Search

Your search keyword '"Fei Ke"' showing total 87 results

Search Constraints

Start Over You searched for: Author "Fei Ke" Remove constraint Author: "Fei Ke" Database Unpaywall Remove constraint Database: Unpaywall
87 results on '"Fei Ke"'

Search Results

4. Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population

11. Tertiary lymphoid structure and decreased CD8+ T cell infiltration in minimally invasive adenocarcinoma

15. Seven interferon gamma response genes serve as a prognostic risk signature that correlates with immune infiltration in lung adenocarcinoma

16. Tertiary Lymphoid Structure and Decreased CD8+ T Cell Infiltration in Minimally Invasive Adenocarcinoma

18. Quality of life with adjuvant gefitinib versus vinorelbine plus cisplatin in patients with completely resected stage II–IIIA (N1–N2) EGFR-mutant non-small-cell lung cancer: Results from the ADJUVANT (CTONG1104) study

23. Radiomics nomogram for prediction disease-free survival and adjuvant chemotherapy benefits in patients with resected stage I lung adenocarcinoma

25. Tuberculosis infection and lung adenocarcinoma: Mendelian randomization and pathway analysis of genome-wide association study data from never-smoking Asian women

29. Germline Predisposition and Copy Number Alteration in Pre-stage Lung Adenocarcinomas Presenting as Ground-Glass Nodules

31. The Unique Spatial-Temporal Treatment Failure Patterns of Adjuvant Gefitinib Therapy: A Post Hoc Analysis of the ADJUVANT Trial (CTONG 1104)

38. ERK inhibition represses gefitinib resistance in non-small cell lung cancer cells

39. Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study

45. Gefitinib (G) versus vinorelbine+cisplatin (VP) as adjuvant treatment in stage II-IIIA (N1-N2) non-small-cell lung cancer (NSCLC) with EGFR-activating mutation (ADJUVANT): A randomized, Phase III trial (CTONG 1104).

50. Association between GWAS-identified lung adenocarcinoma susceptibility loci andEGFRmutations in never-smoking Asian women, and comparison with findings from Western populations

Catalog

Books, media, physical & digital resources